Sucralfate and Lidocain: Antacid 50:50 solution in post esophageal variceal band ligation pain

Abstract

Objective: To compare the effectiveness of pain relief of Sucralfate and lidocain: antacid 50:50 solution in post esophageal variceal band ligation pain.

Methods: All patients who had under gone Esophageal Variceal Band Ligation (EVBL) were included in the study. Patients un-willing to be included in the study or those who didn’t have post EVBL pain were excluded. Patients with post EVBL pains were divided into two groups: one group was given sucralfate and other was given lidocaine: antacid 50:50 solution. Both were inquired about the duration of the pain relief after the medication. The results were analyzed on SPSS 23. Independent samples T-test was performed to find out whether the difference in duration of pain relief was significantly different in the two groups.

Results: Out of 110 patients who have EVBL, 66(60.00%) had pain and 44(40.00%) were pain free. In the pain group 46 (69.7%) were given sucralfate and 20 (30.3%) were given lidocain: antacid 50:50 solution. Mean duration of pain relief in two groups was 2.78 (SD ± 2.096) and 2.5 days (SD ± 0.76) respectively. Independent samples T-test results revealed that there was no statistically significant difference in the duration of pain relief between these two groups with p value 0.426.

Conclusion: Both Sucralfate and Lidocain: antacid 50:50 solutions are effective in relieving the post EVBL pain. However, no statistically significant difference in duration of pain relief was detected in separate groups of patients treated with either treatment.

doi: http://dx.doi.org/10.12669/pjms.324.9645

How to cite this:Hafeez M, Kadir E, Aijaz A. Sucralfate and Lidocain: Antacid 50:50 solution in post esophageal variceal band ligation pain. Pak J Med Sci. 2016;32(4):896-899.   doi: http://dx.doi.org/10.12669/pjms.324.9645

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.